BioNTech SE BNTX
NASDAQ BNTX
$96.85 -1.45 (-1.48%)
At close: Oct 1, 2026 · 4:00 PM EDT

BioNTech SE (BNTX) Depreciation & Amortization (CF) (2018 - 2026)

Updated

BioNTech SE's Depreciation & Amortization (CF) came in at $309.3 million for Q2 2026, up 435.8% from $57.73 million a year earlier and up 117.8% from the prior quarter.

Analysis

BioNTech SE (BNTX) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BioNTech SE reported Depreciation & Amortization (CF) of $788.35 million, up 140.2% year-over-year; for FY2025, it came in at $445.6 million, up 39.9% from FY2024.

  • Depreciation & Amortization (CF) has increased in each of the last eight years, with a five-year compound annual growth rate of 58.8% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $318.44 million in FY2024 (+61.4%), $197.33 million in FY2023 (+56.9%), $125.8 million in FY2022 (+46.2%) and $86.03 million in FY2021 (+94.7%).
  • The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) in data going back to Q4 2018.
  • Year-over-year, Depreciation & Amortization (CF) has increased for 12 consecutive quarters, with growth averaging 123.8% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q2 2026 (growth of 435.8%), and the weakest in Q3 2022 (a decline of 41.8%).
  • Business Quant data shows BNTX's Depreciation & Amortization (CF) at $142.01 million (Q1 2026), $191.83 million (Q4 2025) and $145.2 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 BioNTech SE 24.86 Bn -34.51 Bn 10.00 Mn 309.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 309.30 Mn
Mar 31, 2026 142.01 Mn
Dec 31, 2025 191.83 Mn
Sep 30, 2025 145.20 Mn
Jun 30, 2025 57.73 Mn
Mar 31, 2025 45.02 Mn
Dec 31, 2024 176.75 Mn
Sep 30, 2024 48.76 Mn
Jun 30, 2024 53.74 Mn
Mar 31, 2024 41.61 Mn
Dec 31, 2023 84.78 Mn
Sep 30, 2023 44.96 Mn
Jun 30, 2023 34.74 Mn
Mar 31, 2023 33.70 Mn
Dec 31, 2022 29.59 Mn
Sep 30, 2022 33.78 Mn
Jun 30, 2022 35.43 Mn
Mar 31, 2022 30.98 Mn
Dec 31, 2021 29.74 Mn
Sep 30, 2021 58.02 Mn
API Access

BioNTech SE Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BNTX&period=max&api_key=YOUR_API_KEY